Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 331-340 of 1760 for

Edit search filters
  1. A Study Of Vaccine Therapy In Treating Patients With Malignant Peripheral Nerve Sheath Tumors That Are Recurrent Or Cannot Be Removed By Surgery

    Rochester, MN

  2. Retroperitoneal Lymph Node Dissection In Treating Patients With Testicular Seminoma

    Rochester, MN

  3. A Study Designed To Evaluate The Safety And Efficacy Of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) In Participants With T(11;14)-Positive Relapsed Or Refractory Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  4. A Phase III, Safety, Tolerability And Efficacy Of Combination Treatment Of BL-8040 And G-GSF As Compared To Placebo And G-CSF For ThE MobilizatioN Of HematopoiEtic Stem Cells For Autologous TransplantatIon In SubjectS With MM

    Rochester, MN

  5. Ixazomib Citrate In Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory To Bortezomib

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Chemotherapy For The Treatment Of Patients With Newly Diagnosed Very Low-Risk And Low Risk Fusion Negative Rhabdomyosarcoma

    Rochester, MN

  7. A Phase 1 Trial Of MK-4280 As Monotherapy And In Combination With Pembrolizumab With Or Without Chemotherapy Or Lenvatinib (E7080/MK 7902) In Subjects With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Targeted Therapy Directed By Genetic Testing In Treating Pediatric Patients With Relapsed Or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, Or Histiocytic Disorder

    Rochester, MN

  9. Venetoclax And Vincristine Liposomal In Treating Patients With Relapsed Or Refractory T-cell Or B-cell Acute Lymphoblastic Leukemia

    Rochester, MN

  10. A Phase 1 Dose Escalation And Expansion Study Of TGR-1202 + Ruxolitinib In Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), Post-Essential Thrombocythemia MF (PET-MF), MDS/MPN, Or Polycythemia Vera Resistant To Hydroxyurea

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer